" /> TCHP Regimen - CISMeF





Preferred Label : TCHP Regimen;

NCIt synonyms : Taxotere-Carboplatin-Herceptin-Pertuzumab; TCH Pertuzumab; TCH Plus Pertuzumab Regimen; Taxotere-Carboplatin-Herceptin-Perjeta; Docetaxel/Carboplatin/Trastuzumab/Pertuzumab Regimen; TCH P; TCHP; Docetaxel/Carboplatin/Pertuzumab/Trastuzumab;

NCIt related terms : TCHP (Docetaxel); TCHP (Docetaxel) (trastuzumab-anns); TCHP (Docetaxel) (trastuzumab-dttb); TCHP (Docetaxel) (trastuzumab-pkrb); TCHP (Docetaxel) (trastuzumab-dkst); TCHP (Docetaxel) (trastuzumab-zerc); TCHP (Docetaxel) (trastuzumab-qyyp); TCHP (Docetaxel) (trastuzumab-herw); TCHP (Docetaxel) (trastuzumab-strf); TCHP (Docetaxel, SC Trastuzumab);

NCIt definition : A regimen consisting of docetaxel, carboplatin, trastuzumab and pertuzumab, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.;

NCIt note : Source: NCCN Guidelines 2017;

NCI Metathesaurus CUI : CL524990;

Codes from synonyms : 9412; 128832; 129220; 129123; 129026; 128929; 129414; 129317; 141451; 141452;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.